Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIX100 in Healthy Overweight/Obese Subjects
NCT07675590Phase 1Recruiting
- Sponsor
- TIXiMED
- Start
- Jun 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Phase 1, randomised trial of TIX100 in obesity (4 arms), sponsored by TIXiMED. Primary endpoint: Safety and Tolerability. Started Jun 2026; status: recruiting.
02
Drugs
TIX100
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07675590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07675590.